Private equity investment firm Thoma Bravo will acquire diagnostic medical imaging software vendor AMICAS Inc. for $217 million, the companies announced on Dec. 28.

The $5.35 per share price is 21% higher than Boson-based AMICAS' stock price was when the deal was announced. AMICAS sells radiology and cardiovascular information systems, and radiology and cardiology picture archiving and communication systems.

AMICAS in 2009 paid $39 million to acquire Emageon Inc., which sold complementary systems. AMICAS during the first nine months of 2009 lost $6.1 million on revenue of $62 million. Under acquisition terms, AMICAS may solicit alternative proposals for 45 days starting Dec. 24.

Thoma Bravo, with offices in Chicago and San Francisco, currently has investments in 11 other software/technology companies serving multiple industries.

More information is available at and

--Joseph Goedert

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access